Site Search

Who's Who in Anti-Aging and Regenerative Medicine

Week of June 29, 2009

Mark Rosenberg, MD
Director and Founder of the Institute for Anti‐Aging in South Florida.

Dr. Rosenberg received his undergraduate degree from University of Pennsylvania and graduated from Georgetown University School of Medicine. He completed his residency in emergency medicine at Brooke Army Medical Center, where he won the award of "Teacher and Resident of the Year."

He is a diplomate of the American Academy of Anti‐Aging Medicine. He is a highly sought‐after speaker on topics such as integrative cancer therapy and anti‐aging medicine.

At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Rosenberg will present, Non‐Toxic Cancer Therapies, on Friday, September 11th.

For more information call the A4M today; 1-888-997-0112.
... Continue Reading

Obesity in younger adults linked to an increased risk of pancreatic cancer

A study has found a link between obesity as a young adult and an increased risk of pancreatic cancer, with obesity in middle age linked with poorer survival rates. ... Continue Reading

New chemical nose method for detecting cancer earlier developed at UMASS

Researchers from the University of Massachusetts, Amherst, have developed an entirely new, more effective way to recognize cancer cells. Their “chemical nose” can differentiate between healthy and cancerous cells, as well as between metastatic and non-metastatic cancer cells. ... Continue Reading

Two studies yield new hope for prostate cancer patients

Two new studies -- one evaluating the effect of ipilimumab, a specially engineered antibody that boosts the immune system's ability to fight cancer and one on the effects of green tea -- show promising results for men with prostate cancer. ... Continue Reading

First large-scale trial to study effects of Vitamin D and fish oil on disease prevention to begin in 2010

Beginning next year, Boston researchers will launch the first large-scale trial to determine the effects of vitamin D and fish oil on disease prevention, with a specific focus on African Americans. ... Continue Reading

New cancer treatment delivers “highly promising” results

A study of the drug, Olaparib, has produced “highly promising results” in preliminary drug trials that included 19 patients with inherited forms of advanced breast, ovarian and prostate cancers. The PARP inhibitor could transform how cancer patients are treated in the future. ... Continue Reading

Researchers advance the possibility of genetic testing for colorectal cancer

A "genetic red flag," which indicates the presence of colorectal cancer in more than 50 percent of cases, has been found by an international team of researchers. This finding advances the future possibility of a genetic test for colorectal cancer. ... Continue Reading

New model to investigate cancer stem cells developed by UCLA researchers

A unique model that allows scientists to learn more about lung cancer stem cells -- which many believe are at the root of all types of lung cancers -- has been developed by UCLA researchers. By being able to study the biologic mechanisms of the cells, the hope is that more effective therapies can be developed. ... Continue Reading

New gene therapy cuts off blood supply to tumors, disrupting cancer’s growth

A team of researchers from the University of Florida is the first to successfully target cancer cells through protein binding to tumor endothelial marker 8 (TEM8). This new gene therapy method ultimately promotes blood clotting, which cuts off the blood and nutrient supply to the tumor and thwart its growth. ... Continue Reading

New method for delivering gene therapy directly to cancerous lung tissue shows promise

A novel approach to treating lung cancer -- the use of an aerosol mechanism to deliver cancer-inhibiting genes directly to lung tissues -- has shown early promise in mouse trials. ... Continue Reading